Promoting in vivo remyelination with small molecules: a neuroreparative pharmacological treatment for Multiple Sclerosis. (2017)
Attributed to:
A hub for Engineering and exploiting the stem cell niche
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/srep43545
PubMed Identifier: 28256546
Publication URI: http://europepmc.org/abstract/MED/28256546
Type: Journal Article/Review
Volume: 7
Parent Publication: Scientific reports
ISSN: 2045-2322